-
Faletau still in Tandy's plans despite being left out of Wales squad
-
Power outage hits Google Cloud services, disrupting UK banks
-
Stock markets retreat as oil rises again
-
AI challenges maths by solving the unsolvable
-
Those who profited from fund scandal 'identified': Turkish minister
-
Turkey troops to stay in Syria, Iraq 'until border security ensured', defence minister tells AFP
-
At half a century, Senegal's Orchestra Baobab bets on new generation
-
Kulusevski a 'different man' after emotional Spurs return
-
O'Connor, Sivakov join Seixas at Decathlon CMA CGM
-
Nawaz and Minhas lift Pakistan to 302-9 in England ODI
-
Faletau left out of Wales squad for Nations Championship
-
Mourinho warns no 'untouchable' stars at Real Madrid
-
Rubio says India diversifying oil, trade deal 'very close'
-
Indonesian anger builds over wildfires, toxic haze
-
Erling Haaland Buys Villa at Abu Dhabi’s Jacob & Co Beachfront Living
-
Alaraby Television Network Earns Five GEMA Award Nominations
-
CNN Global Perspectives to Make Middle East Debut in Doha
-
QNB and Qatar Airways Forge Worldwide Digital Payments Alliance
-
Doha Debates Examines Who Should Set the Moral Rules for AI
-
US Midterms Put Control of Congress and Key States at Stake
-
Qatar Amir and Singapore Prime Minister Expand Bilateral Cooperation
-
Qatar Prime Minister Opens Eighth Global Security Forum
-
Cali Biodiversity Fund Struggles After Raising Only $7,085
-
Spain Housing Dispute Puts Landlords at Centre of Election Debate
-
Yan Diomande Finds Form Before Real Madrid Faces Former Club Leipzig
-
October 20 Milestones Trace Decades of Kuwait’s Development
-
Asian Technology Shares Slide as Investors Reassess AI Boom
-
James Maddison Leads Tottenham to First League Victory of Season
-
Marco Rubio Travels to India as Trade Talks Reach Difficult Stage
-
Tonbo Imaging IPO Draws Nearly 136 Times the Shares Offered
-
Brokerages See Eternal Extending Food Delivery and Quick-Commerce Gains
-
Tamil Nadu Adds 25 State-Funded Workdays for Eligible Rural Households
-
Gold Remains Under Pressure as Energy Inflation Clouds Rate Outlook
-
Tamil Nadu and Puducherry Face Return of Very Heavy Rain
-
Industry Groups Outline Four Steps to Help Women Farmers Reach Markets
-
Kemi Badenoch Proposes Ending Childcare Benefit Cliff Edge
-
Late Okafor Penalty Earns Alvechurch FA Cup Replay
-
More Than 52,000 West Midlands Families Use Tax-Free Childcare
-
Low-Cost Homemade Ideas Offer Alternatives for Halloween Costumes
-
Commanders Fear Serious Knee Injury for Terry McLaurin
-
Christiane Amanpour Plans CNN Departure After 43 Years
-
Rays Beat Guardians 7-3 to Secure World Series Place
-
Richard Riehle, Prolific Film and Television Actor, Dies at 78
-
Veteran Character Actor Richard Riehle Dies at 78
-
Hardik Pandya Meets Fan Who Walked 2,390 Kilometres Across India
-
Paras Healthcare Raises ₹652.5 Crore From IPO Anchor Investors
-
Agrograde Introduces AI Optical Sorter for Arecanut Processing
-
World Gold Council Sees Digital Gold Market Tripling by 2031
-
India Warns Unpaid Assessments Are Deepening UN Cash Strain
-
iQOO Neo 12 Set for October 28 China Launch With 144Hz Display
Precidian Funds, Announces the Liquidation of AstraZeneca PLC ADRhedged
NEW YORK CITY, NEW YORK / ACCESS Newswire / January 30, 2026 / Precidian Funds today announced that AstraZeneca PLC ADRhedged™ (the "Series") will liquidate following AstraZeneca PLC's announcement that it will terminate its American Depositary Receipt ("ADR") program in connection with the implementation of a harmonized global listing structure and the direct listing of its ordinary shares on the New York Stock Exchange. This change is expected to become effective on or about February 2, 2026. As a result, all outstanding AstraZeneca PLC ADRs will be mandatorily cancelled and converted into ordinary shares on or around that date.
Due to the termination of the ADR program and the resulting inability of the Series to continue operating in accordance with its investment strategy, the Board of Trustees of Precidian ETFs Trust (the "Trust") has approved a plan of dissolution (the "Plan of Dissolution") for the Series.
Effective the evening of January 29, 2026, the Series ceased accepting creation and redemption orders. The Series will no longer engage in normal investment operations and will thereafter engage solely in activities necessary to wind up its affairs and complete an orderly liquidation.
Upon the mandatory cancellation of the AstraZeneca PLC ADRs, the Series is expected to receive AstraZeneca PLC ordinary shares on February 2, 2026, which the Series anticipates liquidating shortly thereafter. The Series expects to make a final cash distribution to shareholders on or about February 17, 2026, subject to the completion of all necessary administrative and operational processes.
The Series' shares will cease trading on NYSE Arca at the close of business on January 29, 2026.
If you have questions or need assistance, please contact your financial advisor directly or the Series toll-free at 844-954-5333.
SOURCE: Precidian Funds
View the original press release on ACCESS Newswire
O.Gutierrez--AT